MedTrace Logo

Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest

NCT02023814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2013-12-30

No results posted yet for this study

Summary

Stem cell mobilization procedures after chemotherapy and G-CSf performed at our Institution between 2002 and 2013 were reviewed in order to define prognostic factors for optimal harvest

Conditions

  • Blood Stem Cell Harvest Failure

Sponsors & Collaborators

  • Ospedale Santa Croce-Carle Cuneo

    lead OTHER

Principal Investigators

  • Roberto Sorasio · Ospedale S Croce e Carle

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2013-10-31
Completion
2013-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02023814 on ClinicalTrials.gov